Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | TLR4 | O00206 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22277545 | 1.00 | KDM1A (0.33) | KDM1ATLR4CTSLCTSSCTSK | |
| SCHEMBL9405829 | 0.96 | KDM1A (0.35) | KDM1ACTSLCTSSCTSKFFAR4 | |
| SCHEMBL3437363 | 0.96 | KDM1A (0.35) | KDM1ACTSLCTSSCTSKFFAR4 | |
| SCHEMBL12032161 | 0.95 | TLR4 (0.34) | KDM1ATLR4 | |
| SCHEMBL9630399 | 0.92 | RIPK1 (0.38) | TLR4CTSLCTSSCTSKHTR2A | |
| SCHEMBL3437343 | 0.92 | CYP1A2 (0.33) | KDM1ACTSLCTSSCTSKHTR2A | |
| SCHEMBL9630395 | 0.92 | RIPK1 (0.38) | TLR4CTSLCTSSCTSKHTR2A | |
| SCHEMBL16501541 | 0.92 | SLC6A2 (0.32) | KDM1ATLR4CTSLCTSSCTSK | |
| SCHEMBL16769034 | 0.92 | CACNA2D1 (0.34) | KDM1AHTR2AHTR2C | |
| SCHEMBL16769040 | 0.92 | KDM1A (0.33) | KDM1AHTR2AHTR2CFFAR4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10934488-B2 | Polymerizable compound-containing liquid crystal composition and liquid crystal display device using the same | DIC CORPORATION (JP) | 2021-03-02 | — | — | US | disclosed |
| US-20200183203-A1 | REVERSE MODE LIQUID CRYSTAL DEVICE | JNC CORPORATION (JP) | 2020-06-11 | — | — | US | disclosed |
| US-20200071617-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2020-03-05 | — | — | US | disclosed |
| US-10519377-B1 | Liquid crystal composition of negative monomer containing cyclopentyl cyclohexenyl and liquid crystal display element or liquid crystal display thereof | Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd (CN) | 2019-12-31 | — | — | US | disclosed |
| EP-3553595-A1 | REVERSE MODE LIQUID CRYSTAL DEVICE | JNC Corporation (JP) | 2019-10-16 | — | — | EP | disclosed |
| US-20190233730-A1 | POLYMERIZABLE COMPOUND-CONTAINING LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2019-08-01 | — | — | US | disclosed |
| US-10308873-B2 | Polymerizable compound-containing liquid crystal composition and liquid crystal display device using the same | DIC CORPORATION (JP) | 2019-06-04 | — | — | US | disclosed |
| US-10294425-B2 | Liquid crystal composition and liquid crystal display device | JCN CORPORATION (JP) | 2019-05-21 | — | — | US | disclosed |
| US-10287502-B2 | Liquid crystal composition containing polymerizable compound and liquid crystal display element using the same | DIC Corporation (Tokyo) (JP) | 2019-05-14 | — | — | US | disclosed |
| US-10035955-B2 | Liquid-crystal display element | DIC CORPORATION (JP) | 2018-07-31 | — | — | US | disclosed |
| US-20110141418-A1 | LIQUID CRYSTAL COMPOUNDS | QINETIQ LIMITED (GB) | 2011-06-16 | — | — | US | disclosed |
| US-7718232-B2 | Nematic liquid crystal composition and liquid crystal display element that used the composition | DAINIPPON INK & CHEMICAL, INC. (JP) | 2010-05-18 | — | — | US | disclosed |
| US-7670504-B2 | Nematic liquid crystal composition and liquid crystal display device using the same | DAINIPPON INK & CHEMICALS, INC. (JP) | 2010-03-02 | — | — | US | disclosed |
| US-7670504-B2 | Nematic liquid crystal composition and liquid crystal display device using the same | DAINIPPON INK & CHEMICALS, INC. (JP) | 2010-03-02 | — | — | US | disclosed |
| US-7651630-B2 | Difluorobenzene derivative and nematic liquid crystal composition using the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2010-01-26 | — | — | US | disclosed |
| US-20090050843-A1 | DIFLUOROBENZENE DERIVATIVE AND NEMATIC LIQUID CRYSTAL COMPOSITION USING THE SAME | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20080149889-A1 | Nematic Liquid Crystal Composition and Liquid Crystal Display Element That Used the Composition | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2008-06-26 | — | — | US | disclosed |
| US-20080111107-A1 | Nematic Liquid Crystal Composition And Liquid Crystal Display Device Using The Same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2008-05-15 | — | — | US | disclosed |
| EP-1860089-A1 | DIFLUOROBENZENE DERIVATIVE AND NEMATIC LIQUID CRYSTAL COMPOSITION MAKING USE OF THE SAME | Dainippon Ink and Chemicals, Incorporated (JP) | 2007-11-28 | — | — | EP | disclosed |
| US-7226644-B2 | Chroman derivative and liquid-crystal composition containing the compound | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090050843-A1 | DIFLUOROBENZENE DERIVATIVE AND NEMATIC LIQUID CRYSTAL COMPOSITION USING THE SAME | HCN2, TRPV2, TRPV5 | KDM1A 2091/4885TLR4 4691/4885CTSL 4770/4885 |
| US-20110141418-A1 | LIQUID CRYSTAL COMPOUNDS | HTR3D, HTR3C, SFXN3 | KDM1A 3188/4885TLR4 1581/4885CTSL 618/4885 |
| US-20080111107-A1 | Nematic Liquid Crystal Composition And Liquid Crystal Display Device Using The Same | PIEZO1, KIF20B, VCL | KDM1A 1567/4885TLR4 4064/4885CTSL 3424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.